Kardiyak Nedenlere Bağlı İzole Fetal Asit

Year 2014, Volume: 12 Issue: 3, 190 - 193, 01.12.2014

Vehbi Doğan Ayşe Hendekçi Bilal Özelce Şahin Takçı Deniz Anuk İnce Nihan Güneri Doğan

https://doi.org/10.4274/jcp.52523

Abstract

Fetal asit peritoneal kavitede sıvı birikmesi olarak tanımlanmaktadır. İzole olarak görülebileceği gibi hidrops fetalisin erken bir bulgusu olarak da gelişebilir. Fetal asit saptandığında prognoz ve tedavinin altta yatan nedene göre değişiklik göstermesi nedeniyle dikkatli bir inceleme yapılmalıdır. Non-immünolojik fetal asit, konjenital enfeksiyonlar, genitoüriner ve gastrointestinal anomaliler, genetikmetabolik hastalıklar ve kalp hastalıkları gibi birçok nedene bağlı gelişebilen nadir bir durumdur. Bu makalede kardiyak nedenlere bağlı fetal asit saptanan ve doğum sonrası tedavi ile düzelen iki hasta sunulmuştur

Keywords

Fetal asit, fetal aritmi, fetal miyokardit, fetal kalp yetmezliği

Isolated Fetal Ascite Associated with Cardiac Diseases

Abstract

Fetal ascite is defined as fluid accumulation in peritoneal cavity. It can be seen as isolated disease or an early sign of hydrops fetalis. Once fetal ascite is detected, a careful examination for hydops fetalis and possible underlying disease is necessary, since its prognosis and treatment depends mostly on the cause. Nonimmunologic fetal ascite is an uncommon problem occurring for many reasons, such as urinary tract obstruction, congenital infections, genetic and metabolic diseases, gastrointestinal diseases and cardiovascular diseases. Here in this report we present two isolated fetal ascite that occurred secondary to cardiac diseases

Keywords

Fetal ascite, fetal arrhythmia, fetal heart failure, fetal myocarditis

References

• 1. Haan TR, Oepkes D, Beersma MFC, Walther FJ. Aetiology, diagnosis and treatment of hydrops foetalis. Current Pediatric Reviews 2005;1:63-72.
• 2. Machin GA. Hydrops revisited: literature review of 1,414 cases published in the 1980s. Am J Med Genet 1989;34:366-90.
• 3. Zelop C, Benacerraf BR. The causes and natural history of fetal ascites. Prenat Diagn 1994;14:941-6.
• 4. Knisely AS. The pathologist and the hydropic placenta, fetus or infant. Semin Perinatol 1995;19:525-31.
• 5. Schmider A, Henrich W, Reles A, Kjos S, Dudenhausen JW. Etiology and prognosis of fetal ascites. Fetal Diagn Ther 2003;18:230-6.
• 6. Rodríguez MM, Bruce JH, Jimenez XF, Romaguera RL, Bancalari E, García OL, et al. Nonimmune hydrops fetalis in the liveborn: series of 32 autopsies. Pediatr Dev Pathol 2005;8:369- 78.
• 7. Arikan İ, Barut A, Harma M, Harma Mİ, Dogan S. Isolated Foetal Ascites: A Case Report. J Med Cases 2012;3:110-2.
• 8. Benirschke K, Swartz WH, Leopold G, Sahn D. Hydrops due to myocarditis in a fetus. Am J Cardiovasc Pathol 1987;1:131-3.
• 9. Knilans TK. Cardiac abnormalities associated with hydrops fetalis. Semin Perinatol 1995;19:483-92.s
• 10. Von Kaisenberg CS, Bender G, Scheewe J, Hirt SW, Lange M, Stieh J, et al. A case of fetal parvovirus B19 myocarditis, terminal cardiac heart failure, and perinatal heart transplantation. Fetal Diagn Ther 2001;16:427–32.
• 11. Matsubara S, Morimatsu Y, Shiraishi H, Kuwata T, Ohkuchi A, Izumi A, et al. Fetus with heart failure due to congenital atrioventricular block treated by maternally administered ritodrine. Arch Gynecol Obstet 2008;278:85-8.
• 12. Horng SG, Chao AS, Cheng PJ, Soong YK. Isolated fetal ascites: five cases report. Changgeng Yi Xue Za Zhi 1998;21:72-7.
• 13. Sohan K, Carroll SG, de la Fuente S, Soothill P, Kyle P. Analysis of outcome in hydrops fetalis in relation to gestational age at diagnosis, cause and treatment. Acta Obstet Gynecol Scand 2001;88:726-30.
• 14. El Bishry G. The outcome of isolated fetal ascites. Eur J Obstet Gynecol Reprod Biol 2008;137:43-6.
• 15. Nose S, Usui N, Soh H, Kamiyama M, Tani G, Kanagawa T, et al. The prognostic factors and the outcome of primary isolated fetal ascites. Pediatr Surg Int 2011;27:799-804.
• 16. Kıykaç Altınbaş Ş, Kandemir O, Yalvaç S, Göktolga Ü. Ultrasonografik izlemde spontan remisyona uğrayan izole fetal asit olgu sunusu. Perinatoloji Dergisi 2012;20:153-5.
• 17. Simpson JM, Milburn A, Yates RW, Maxell DJ, Sharland GK. Outcome of intermittent tachyarrhythmias in the fetus. Pediatr Cardiol 1997;18:78-82.
• 18. Cuneo BF, Strasburger JF. Management strategy for fetal tachycardia. Obstet Gynecol 2000;96:575-81.
• 19. Krapp M, Baschat AA, Gembruch U, Geipel, Germer U. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002;19:158-64.